SOPHiA GENETICS insider plans sale of 37,000 shares

SOPHiA GENETICS reports that an affiliate, acting through Morgan Stanley Smith Barney LLC Executive Financial Services, has filed to sell up to 37,000 shares of common stock classified as founders shares.

Rhea-AI Filing Summary

SOPHiA GENETICS reports that an affiliate, acting through Morgan Stanley Smith Barney LLC Executive Financial Services, has filed to sell up to 37,000 shares of common stock classified as founders shares. The proposed sale amount is listed at $234,210.00.

The filing also details prior sales under a Rule 10b5-1 trading plan for Jurgi Camblong, including 65,269 common shares sold on June 30, 2026 for $398,632.27 and 50,069 shares sold on June 26, 2026 for $290,329.01, along with several smaller transactions between May and July 2026.

Key Figures

Proposed shares to be sold: 37,000 shares Proposed aggregate sale value: $234,210.00 10b5-1 sale on 06/30/2026: 65,269 shares for $398,632.27 +2 more

5 metrics

Proposed shares to be sold 37,000 shares Common stock founders shares in current Form 144

Proposed aggregate sale value $234,210.00 Value associated with 37,000 common shares

10b5-1 sale on 06/30/2026 65,269 shares for $398,632.27 Common stock sold under 10b5-1 plan

10b5-1 sale on 06/26/2026 50,069 shares for $290,329.01 Common stock sold under 10b5-1 plan

10b5-1 sale on 07/20/2026 24,381 shares for $153,445.04 Common stock sold under 10b5-1 plan

Key Terms

Founders Shares, 10b5-1, Form 144, Executive Financial Services

4 terms

Founders Shares financial

"Common | 03/18/2021 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

10b5-1 regulatory

"10b5-1 Sales for JURGI CAMBLONG La Piece 12"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"144: Securities Information Common | Morgan Stanley Smith Barney"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does SOPH’s latest Form 144 filing disclose?

The filing discloses an intent to sell up to 37,000 SOPH common shares of founders stock through Morgan Stanley Smith Barney, with a proposed aggregate sale value of $234,210.00, and lists recent Rule 10b5-1 plan sales.

How many SOPH shares are proposed for sale in this Form 144?

The filer proposes to sell up to 37,000 shares of SOPH common stock. These are described as founders shares and are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, according to the Form 144 disclosure.

What is the aggregate value of SOPH shares covered by the proposed sale?

The proposed sale covers an aggregate value of $234,210.00 in SOPH common shares. This figure is tied to the 37,000 founders shares indicated in the Form 144 filing submitted via Morgan Stanley Smith Barney.

Who is the selling security holder in SOPH’s Form 144?

The sales are associated with Jurgi Camblong, with transactions executed under a 10b5-1 trading plan. The filing notes sales of SOPH common shares from an address in Rolle, Switzerland across multiple dates in May–July 2026.

What recent 10b5-1 sales of SOPH stock are detailed in the filing?

Recent 10b5-1 sales include 65,269 shares for $398,632.27 on June 30, 2026 and 50,069 shares for $290,329.01 on June 26, 2026, plus additional transactions ranging from 1,373 to 24,381 shares in May–July 2026.

On which exchange are the SOPH shares in this Form 144 listed?

The common shares referenced in the Form 144 are listed on NASDAQ. The filing specifies NASDAQ as the trading market for the SOPH common stock covered by the proposed sale and the recent 10b5-1 transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/21/2026 - 04:25 PM Accepted by SEC EDGAR 07/21/2026 - 04:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007050
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	JURGI CAMBLONG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	37000	234210.00	71790366	07/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2021	Founders Shares	Issuer			37000	03/18/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/20/2026	24381	153445.04
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/10/2026	8500	47791.25
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/07/2026	17685	93327.28
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/06/2026	22486	118163.93
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/30/2026	65269	398632.27
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/29/2026	18410	108058.02
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/26/2026	50069	290329.01
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/25/2026	1373	7826.10
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/10/2026	8500	44500.90
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/19/2026	4486	20657.58
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/11/2026	8500	43241.20

144: Remarks and Signature

Remarks
Date of Notice	07/21/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jurgi Camblong
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)